Schrodinger, Inc. - Common Stock (NQ:SDGR)

26.39 -0.90 (-3.30%)

Delayed Quote Updated: 4:00 PM EDT, Oct 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Schrodinger, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Schrödinger (SDGR) Q2 2026 Earnings Call Transcript ↗

August 12, 2026

AI co-scientist Bunsen drives productivity gains amid software model shift.

Via The Motley Fool

Topics Artificial Intelligence Earnings

Schrodinger Q2 Earnings Call Highlights ↗

August 06, 2026

Schrodinger (NASDAQ:SDGR) said second-quarter annual contract value growth accelerated as demand broadened across large pharmaceutical customers, biotechnology companies and materials-science...

Via MarketBeat

Topics Artificial Intelligence Earnings

Schrodinger (NASDAQ:SDGR) Q2 Results Beat Expectations; Guidance Raised ↗

August 05, 2026

Via Chartmill

Recursion Pharmaceuticals vs. Schrödinger: Which Healthcare Stock Is a Better Buy in 2026? ↗

June 02, 2026

Two AI-driven disruptors, one biotech-focused, one software-first, post double-digit growth but diverge sharply on risk, cash flow, and valuation.

Via The Motley Fool

Topics Artificial Intelligence

Schrödinger Inc (NASDAQ:SDGR) Q1 2026 Earnings: Revenue Beat Fails to Offset Loss Miss, Stock Slides ↗

May 05, 2026

Via Chartmill

Schrödinger Inc (NASDAQ:SDGR) Posts Q4 Earnings Beat Amid Strategic Software Model Shift ↗

February 25, 2026

Via Chartmill

Topics Earnings

My Top 3 Biotech Stocks for May 2026 ↗

May 20, 2026

As FDA activity accelerates and big pharma searches for its next generation of blockbuster drugs, select biotech companies are beginning to stand out from the crowd.

Via The Motley Fool

Topics Artificial Intelligence Intellectual Property

Schrödinger (SDGR) Q1 2026 Earnings Transcript ↗

May 05, 2026

Schrödinger (SDGR) Q1 2026 Earnings Transcript

Via The Motley Fool

Topics Artificial Intelligence

The Biotechnology Renaissance: AI and Capital Collide in a Multi-Trillion Dollar Pivot

February 17, 2026

As of February 17, 2026, the biotechnology sector is undergoing its most significant structural transformation in decades, a period now widely termed the "Biotechnology Renaissance." Following a...

Via MarketMinute

Topics Artificial Intelligence Economy Initial Public Offering

Earnings Scheduled For November 5, 2025 ↗

November 05, 2025

Via Benzinga

What 4 Analyst Ratings Have To Say About Schrodinger ↗

August 18, 2025

Via Benzinga

AI’s ‘Penicillin Moment’: How Generative Models Are Slashing Decades of Antibiotic Research into Months

February 06, 2026

In a breakthrough that many are calling the "Penicillin Moment" of the 21st century, researchers at the Massachusetts Institute of Technology, led by bioengineering pioneer James Collins, have...

Via TokenRing AI

Topics Artificial Intelligence

The Biotech Renaissance: Scientific Breakthroughs and M&A Frenzy Spark a New Bull Market

January 22, 2026

The U.S. biotech sector has officially entered a new golden age. As of January 22, 2026, the industry is witnessing a "renaissance" that has effectively erased the memories of the grueling three-year...

Via MarketMinute

Topics Artificial Intelligence ETFs Initial Public Offering

Schrodinger Downgraded By Citi After Ending Blood Cancer Drug Trial Tied To 2 Deaths; Retail Voices Concern ↗

August 15, 2025

Via Stocktwits

Schrödinger Discontinues Clinical Program After Two Patient Deaths ↗

August 14, 2025

Via Stocktwits

From Silicon to Syringes: Nvidia’s AI Dominance Solidified Through Landmark Eli Lilly Alliance

January 12, 2026

In a move that signals the definitive convergence of high-performance computing and biotechnology, NVIDIA Corporation (NASDAQ: NVDA) and Eli Lilly and Company (NYSE: LLY) announced a massive $1 billion...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

Certara’s Volatility: From a 23% Earnings Plunge to a $3 Million Institutional Vote of Confidence

January 05, 2026

The biosimulation market was sent into a tailspin in the closing months of 2025 as Certara (Nasdaq:CERT), a global leader in model-informed drug development, saw its market valuation crater by 23%. The...

Via MarketMinute

Topics Earnings

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

December 20, 2025

The famous investor's funds were active buyers in the run-up to the holidays.

Via The Motley Fool

Topics Bonds ETFs

Beyond the Hype: AI’s Quiet Revolution in Niche Sectors Reshapes Industries from Medicine to Agriculture

December 01, 2025

Artificial intelligence, often spotlighted for its advancements in mainstream applications like conversational agents and autonomous vehicles, is quietly orchestrating a profound transformation across...

Via TokenRing AI

Topics Artificial Intelligence Economy Emissions

Moss Spores Defy the Void: A Tiny Plant’s Giant Leap for Astrobiology and Off-World Ecosystems

November 24, 2025

Recent groundbreaking research has revealed the astonishing resilience of moss spores, with over 80% surviving a nine-month exposure to the brutal conditions on the exterior of the International Space...

Via TokenRing AI

Topics Artificial Intelligence

AI Unlocks Gene-Editing Revolution: $2 Million Grant Propels Disease Cures

November 06, 2025

A groundbreaking $2 million grant from the National Institutes of Health (NIH) is set to dramatically accelerate advancements in gene-editing technology, with artificial intelligence (AI) emerging as...

Via TokenRing AI

Topics Artificial Intelligence Climate Change Intellectual Property

AI Unlocks Cosmic Secrets: Revolutionizing Discovery in Physics and Cosmology

November 05, 2025

Artificial Intelligence (AI) is ushering in an unprecedented era of scientific discovery, fundamentally transforming how researchers in fields like cosmology and physics unravel the universe's most...

Via TokenRing AI

Topics Artificial Intelligence

10 Health Care Stocks Whale Activity In Today's Session ↗

November 03, 2025

Via Benzinga

Navigating the Future: Unlocking Investment Opportunities in High-Growth Sectors

October 04, 2025

As of October 2025, the global financial markets are undergoing a profound transformation, driven by an accelerating wave of technological innovation and a pressing global imperative for...

Via MarketMinute

Topics Artificial Intelligence Climate Change Economy

Expert Outlook: Schrodinger Through The Eyes Of 5 Analysts ↗

September 30, 2025

Via Benzinga

Lilly's AI Gambit: TuneLab Poised to Reshape Biotech Drug Discovery Landscape

September 19, 2025

Eli Lilly and Company (NYSE: LLY) has unveiled its groundbreaking TuneLab Platform, an artificial intelligence (AI) and machine learning (ML) initiative designed to democratize advanced drug discovery...

Via MarketMinute

Topics Animal Testing Artificial Intelligence Intellectual Property

This Cisco Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday ↗

August 15, 2025

Via Benzinga

This AZZ Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗

August 14, 2025

Via Benzinga

Powering Progress: AI's Insatiable Energy Appetite and Biotech's Dual Dawn

August 27, 2025

The global economy in 2025 is navigating a landscape profoundly reshaped by the escalating demands of Artificial Intelligence (AI) and transformative shifts in healthcare. While the burgeoning energy...

Via MarketMinute

Topics Artificial Intelligence Economy Emissions

Schrödinger (SDGR) Q2 2025 Earnings Transcript ↗

August 06, 2025

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.